SHANE KELLER: Open Payments
NPI 1194768911 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$783 in 40 payments from 16 companies in 2025. Trend: 2023 $938 · 2024 $1,043 · 2025 $783
Food & beverage: $783
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $204 |
| Novo Nordisk Inc | 4 | $102 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Collegium Pharmaceutical, Inc. | 3 | $61 |
| PFIZER INC. | 2 | $47 |
| Exact Sciences Corporation | 2 | $41 |
| Amgen Inc. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
Products named: VRAYLAR, Wegovy, Jornay PM, UBRELVY, QULIPTA, Cologuard Collection Kit, Kerendia, XIFAXAN.
Industry payments across TX — which companies pay providers there.
